Literature DB >> 6881432

Case-control study of Mastomys natalensis and humans in Lassa virus-infected households in Sierra Leone.

R A Keenlyside, J B McCormick, P A Webb, E Smith, L Elliott, K M Johnson.   

Abstract

Lassa virus infection and antibodies were studied in households where Lassa fever cases occurred, and compared to those in nearest neighbor houses and "far" houses located across the village from case houses. Seventy-nine percent of all rodents caught in the houses were Mastomys, the natural reservoir of Lassa virus. Rodent infection was not randomly distributed, but rather focal. Thirty-nine percent of the Mastomys in case houses were viremic, compared to 3.7% in control houses. Human antibody prevalence in case houses was 30%, compared to 20% in non-case houses (P less than 0.05, chi-square test, df = 2). Neither seroconversions nor antibody prevalence rates were associated with household size or number of persons per room. Trapping of rodents in half of the case and control houses resulted in a Mastomys reduction ranging from 2.2- to 3.3-fold. This reduction failed to significantly reduce the seroconversion rate to Lassa virus in the people of trapped houses compared to those in untrapped ones. More complete trapping will be needed in order to better evaluate this procedure as a means of interruption of Lassa virus transmission in endemic villages.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6881432     DOI: 10.4269/ajtmh.1983.32.829

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  31 in total

Review 1.  Lassa fever: epidemiology, clinical features, and social consequences.

Authors:  J Kay Richmond; Deborah J Baglole
Journal:  BMJ       Date:  2003-11-29

2.  A Proteomics Survey of Junín Virus Interactions with Human Proteins Reveals Host Factors Required for Arenavirus Replication.

Authors:  Christopher M Ziegler; Philip Eisenhauer; Jamie A Kelly; Loan N Dang; Vedran Beganovic; Emily A Bruce; Benjamin R King; David J Shirley; Marion E Weir; Bryan A Ballif; Jason Botten
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

3.  Serological and biological evidence that Lassa-complex arenaviruses are widely distributed in Africa.

Authors:  M P Kiley; R Swanepoel; S W Mitchell; J V Lange; J P Gonzalez; J B McCormick
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

4.  The use of novel epitope-tagged arenaviruses reveals that Rab5c-positive endosomal membranes are targeted by the LCMV matrix protein.

Authors:  Christopher M Ziegler; Emily A Bruce; Jamie A Kelly; Benjamin R King; Jason W Botten
Journal:  J Gen Virol       Date:  2018-02       Impact factor: 3.891

5.  Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry.

Authors:  Masayuki Shimojima; Ute Ströher; Hideki Ebihara; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

6.  Genetic diversity among Lassa virus strains.

Authors:  M D Bowen; P E Rollin; T G Ksiazek; H L Hustad; D G Bausch; A H Demby; M D Bajani; C J Peters; S T Nichol
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Effective vaccine for lassa fever.

Authors:  S P Fisher-Hoch; L Hutwagner; B Brown; J B McCormick
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 8.  Pathogenesis of Lassa fever.

Authors:  Nadezhda E Yun; David H Walker
Journal:  Viruses       Date:  2012-10-09       Impact factor: 5.048

9.  Housing equity for health equity: a rights-based approach to the control of Lassa fever in post-war Sierra Leone.

Authors:  J Daniel Kelly; M Bailor Barrie; Rachel A Ross; Brian A Temple; Lina M Moses; Daniel G Bausch
Journal:  BMC Int Health Hum Rights       Date:  2013-01-02

Review 10.  Advanced vaccine candidates for Lassa fever.

Authors:  Igor S Lukashevich
Journal:  Viruses       Date:  2012-10-29       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.